375 related articles for article (PubMed ID: 17262061)
41. Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning.
Lange T; Hubmann M; Burkhardt R; Franke GN; Cross M; Scholz M; Leiblein S; Al-Ali HK; Edelmann J; Thiery J; Niederwieser D
Leukemia; 2011 Mar; 25(3):498-505. PubMed ID: 21135860
[TBL] [Abstract][Full Text] [Related]
42. Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival.
Lamba R; Abella E; Kukuruga D; Klein J; Savasan S; Abidi MH; Mohamed A; Peres E
Leukemia; 2004 Oct; 18(10):1681-6. PubMed ID: 15318247
[TBL] [Abstract][Full Text] [Related]
43. Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells.
Thiede Ch; Lutterbeck K; Oelschlägel U; Kiehl M; Steudel Ch; Platzbecker U; Brendel C; Fauser AA; Neubauer A; Ehninger G; Bornhäuser M
Ann Hematol; 2002; 81 Suppl 2():S27-8. PubMed ID: 12611065
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.
Kwon M; Martínez-Laperche C; Infante M; Carretero F; Balsalobre P; Serrano D; Gayoso J; Pérez-Corral A; Anguita J; Díez-Martín JL; Buño I
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1235-42. PubMed ID: 22281301
[TBL] [Abstract][Full Text] [Related]
45. Hemopoietic chimerism following stem cell transplantation.
McCann SR; Crampe M; Molloy K; Lawler M
Transfus Apher Sci; 2005 Feb; 32(1):55-61. PubMed ID: 15737874
[TBL] [Abstract][Full Text] [Related]
46. Platelet chimerism by polymerase chain reaction (PCR) utilizing variable number of tandem repeats (VNTR) in allogeneic stem cell transplant in children: a new novel approach to full chimerism analysis.
Chou PM; Olszewski M; Huang W; Silva M; Kletzel M
Bone Marrow Transplant; 2003 Oct; 32(8):825-8. PubMed ID: 14520429
[TBL] [Abstract][Full Text] [Related]
47. Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.
Hoelle W; Beck JF; Dueckers G; Kreyenberg H; Lang P; Gruhn B; Führer M; Niethammer D; Klingebiel T; Bader P
Bone Marrow Transplant; 2004 Jan; 33(2):219-23. PubMed ID: 14647253
[TBL] [Abstract][Full Text] [Related]
48. Clinical utility of chimerism status assessed by lineage-specific short tandem repeat analysis: experience from four cases of allogeneic stem cell transplantation.
Goh RY; Cho SS; Song YJ; Heo K; Oh SY; Kim SH; Kwon HC; Kim HJ; Han JY
Korean J Lab Med; 2009 Aug; 29(4):277-81. PubMed ID: 19726887
[TBL] [Abstract][Full Text] [Related]
49. Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia.
Formánková R; Honzátková L; Sieglová Z; Starý J; Sedlácek P; Brdicka R
Bone Marrow Transplant; 2000 Feb; 25(4):453-6. PubMed ID: 10723591
[TBL] [Abstract][Full Text] [Related]
50. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
Boeck S; Hamann M; Pihusch V; Heller T; Diem H; Rolf B; Pihusch R; Kolb HJ; Pihusch M
Bone Marrow Transplant; 2006 Jan; 37(1):57-64. PubMed ID: 16258529
[TBL] [Abstract][Full Text] [Related]
51. Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
Yoshimi A; Niemeyer CM; Bohmer V; Duffner U; Strahm B; Kreyenberg H; Dilloo D; Zintl F; Claviez A; Wössmann W; Kremens B; Holter W; Niethammer D; Beck JF; Kontny U; Nöllke P; Klingebiel T; Bader P
Br J Haematol; 2005 May; 129(4):542-9. PubMed ID: 15877738
[TBL] [Abstract][Full Text] [Related]
52. Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV.
Jaksch M; Uzunel M; Remberger M; Sundberg B; Mattsson J
Clin Transplant; 2005 Jun; 19(3):346-9. PubMed ID: 15877796
[TBL] [Abstract][Full Text] [Related]
53. Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse?
Bader P; Beck J; Schlegel PG; Handgretinger R; Niethammer D; Klingebiel T
Bone Marrow Transplant; 1997 Jul; 20(1):79-81. PubMed ID: 9232263
[TBL] [Abstract][Full Text] [Related]
54. Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor-type chimerism: report of two cases.
Ohashi H; Kato C; Fukami S; Saito H; Hamaguchi M
Am J Hematol; 2005 Jun; 79(2):142-6. PubMed ID: 15929112
[TBL] [Abstract][Full Text] [Related]
55. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
[TBL] [Abstract][Full Text] [Related]
56. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
57. Underestimation of recipient DNA in bone marrow by post-transplant chimerism analyses using DNA extracted from EDTA-collected aspirate samples in pediatric acute myeloid leukemia.
Park CH; Song MJ; Kim HJ; Ki CS; Lee SH; Yoo KH; Sung KW; Koo HH; Kim SH
Ann Clin Lab Sci; 2011; 41(2):138-43. PubMed ID: 21844571
[TBL] [Abstract][Full Text] [Related]
58. Monitoring of acute myeloid leukemia patients after allogeneic stem cell transplantation employing semi-automated CD34+ donor cell chimerism analysis.
Hoffmann JC; Stabla K; Burchert A; Volkmann T; Bornhäuser M; Thiede C; Neubauer A; Brendel C
Ann Hematol; 2014 Feb; 93(2):279-85. PubMed ID: 24352219
[TBL] [Abstract][Full Text] [Related]
59. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.
Al-Ali H; Cross M; Lange T; Freund M; Dölken G; Niederwieser D
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407
[TBL] [Abstract][Full Text] [Related]
60. Second allogeneic stem cell transplantation in myeloid malignancies.
Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]